{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:40:43Z","timestamp":1770820843615,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.clinthera.2016.08.005","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T16:01:02Z","timestamp":1473436862000},"page":"2006-2015","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Principles of Anti-infective Dosing in Pregnancy"],"prefix":"10.1016","volume":"38","author":[{"given":"Avinash S.","family":"Patil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica S.","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah K.","family":"Dotters-Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria S.","family":"Schmoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell L.","family":"Onslow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.08.005_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ajog.2004.04.025","article-title":"Prescription drug use in pregnancy","volume":"191","author":"Andrade","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"51","key":"10.1016\/j.clinthera.2016.08.005_bib2","first-page":"e1","article-title":"National Birth Defects Prevention Study. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008","volume":"205","author":"Mitchell","year":"2011","journal-title":"Am J Obstet Gynecol"},{"issue":"54","key":"10.1016\/j.clinthera.2016.08.005_bib3","first-page":"502","article-title":"Health care providers\u2019 use of a drug information service for pregnancy-related inquiries","volume":"2014","author":"Patil","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.clinthera.2016.08.005_bib4","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1067\/mcp.2000.111184","article-title":"Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics","volume":"68","author":"Chen","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.08.005_bib5","first-page":"e513","article-title":"Drugs indicated for use during pregnancy","volume":"18","author":"Lalonde","year":"2011","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib6","first-page":"72063","article-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule","volume":"79","year":"2014","journal-title":"Fed Regist"},{"key":"10.1016\/j.clinthera.2016.08.005_bib7","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3389\/fphar.2014.00065","article-title":"Physiologic and pharmacokinetic changes in pregnancy","volume":"5","author":"Costantine","year":"2014","journal-title":"Frontiers Pharmacol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib8","series-title":"Williams Obstetrics","article-title":"Maternal physiology","author":"Cunningham","year":"2013"},{"key":"10.1016\/j.clinthera.2016.08.005_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1471-0528.1990.tb16246.x","article-title":"Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance","volume":"97","author":"Robson","year":"1990","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib10","series-title":"Creasy and Resnik\u2019s maternal-fetal medicine: Principles and practice","author":"Creasy","year":"2009"},{"key":"10.1016\/j.clinthera.2016.08.005_bib11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/clpt.1986.183","article-title":"Theophylline pharmacokinetics in pregnancy","volume":"40","author":"Frederiksen","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2016.08.005_bib12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ncl.2012.05.001","article-title":"Physiologic adaptations to pregnancy","volume":"30","author":"Chang","year":"2012","journal-title":"Neurol Clin"},{"key":"10.1016\/j.clinthera.2016.08.005_bib13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/AOG.0b013e3182238c31","article-title":"ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery","volume":"117","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib14","first-page":"CD007482","article-title":"Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section","author":"Smaill","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2016.08.005_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0895-4356(93)90035-Y","article-title":"Cefazolin compared with cefoxitin for cesarean section prophylaxis: the use of a two-stage study design","volume":"46","author":"Currier","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib16","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/0002-9378(90)91290-S","article-title":"Antibiotic prophylaxis: is there a difference?","volume":"162","author":"Faro","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1592\/phco.27.8.1081","article-title":"Antimicrobial dosing considerations in obese adult patients","volume":"27","author":"Pai","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.clinthera.2016.08.005_bib18","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1128\/AAC.02613-13","article-title":"Pharmacokinetics of prophylactic cefazolin in parturients undergoing cesarean delivery","volume":"58","author":"Elkomy","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.clinthera.2016.08.005_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/AOG.0b013e31820b95e4","article-title":"Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery","volume":"117","author":"Pevzner","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"415","key":"10.1016\/j.clinthera.2016.08.005_bib20","first-page":"e1","article-title":"Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women","volume":"213","author":"Swank","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1089\/sur.2012.040","article-title":"Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug","volume":"14","author":"Stitely","year":"2013","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/j.clinthera.2016.08.005_bib22","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/AOG.0000000000000789","article-title":"Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial","volume":"125","author":"Maggio","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/AOG.0000000000001064","article-title":"Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women","volume":"126","author":"Ahmadzia","year":"2015","journal-title":"Obstet Gynecol"},{"issue":"751","key":"10.1016\/j.clinthera.2016.08.005_bib24","first-page":"e1","article-title":"A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study","volume":"214","author":"Ward","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"812","key":"10.1016\/j.clinthera.2016.08.005_bib25","first-page":"e1","article-title":"Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis","volume":"212","author":"Sutton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: results of prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2016.08.005_bib27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/657309","article-title":"Influenza vaccine given to pregnant women reduces hospitalizations due to influenza in their infants","volume":"51","author":"Benowitz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.clinthera.2016.08.005_bib28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/QCO.0b013e3283607a58","article-title":"Maternal immunization as a strategy to decrease susceptibility to infection in newborn infants","volume":"26","author":"Lindsey","year":"2013","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.clinthera.2016.08.005_bib29","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ogc.2014.08.001","article-title":"Maternal immunization to benefit the mother, fetus, and infant","volume":"41","author":"Swamy","year":"2014","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.clinthera.2016.08.005_bib30","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/AOG.0000000000001066","article-title":"Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy","volume":"126","author":"Sukumaran","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib32","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.vaccine.2015.08.035","article-title":"Maternal benefits of immunization during pregnancy","volume":"33","author":"Swamy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2016.08.005_bib33","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2016.08.005_bib34","doi-asserted-by":"crossref","first-page":"e79040","DOI":"10.1371\/journal.pone.0079040","article-title":"Maternal and neonatal outcomes among pregnant women with 2009 pandemic influenza A(H1N1) Illness in Florida, 2009-2010: A population-based cohort study","volume":"8","author":"Doyle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2016.08.005_bib35","doi-asserted-by":"crossref","unstructured":"Committee on Obstetric Practice and Immunization Expert Work Group; Centers for Disease Control and Prevention\u2019s Advisory Committee on Immunization, United States; American College of Obstetricians and Gynecologists. Committee opinion no. 608: influenza vaccination during pregnancy. Obstet Gynecol. 2014;124:648-51.","DOI":"10.1097\/01.AOG.0000453599.11566.11"},{"key":"10.1016\/j.clinthera.2016.08.005_bib36","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2015.08.093","article-title":"What determines uptake of pertussis in vaccine in pregnancy? A cross sectional survey in an ethnically diverse population of pregnant women in London","volume":"33","author":"Donaldson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.clinthera.2016.08.005_bib37","doi-asserted-by":"crossref","first-page":"e009356","DOI":"10.1136\/bmjopen-2015-009536","article-title":"Infant outcomes after exposure to Tdap vaccine in pregnant: an observational study","volume":"6","author":"Walls","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2016.08.005_bib38","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.ajog.2015.08.040","article-title":"Acute chorioamnionitis and funisitis: definition, pathologic features, and clinical significance","volume":"213","author":"Kim","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib39","series-title":"Obstetrics: Normal and Problem Pregnancies","author":"Gabbe","year":"2002"},{"key":"10.1016\/j.clinthera.2016.08.005_bib40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00006250-198812000-00001","article-title":"A randomized trial of intrapartum versus immediate postpartum treatment of women with intra-amniotic infection","volume":"72","author":"Gibbs","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib41","first-page":"124","article-title":"Antibiotic concentration in maternal blood, cord blood, and placental membranes in chorioamnionitis","volume":"72","author":"Gilstrap","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1055\/s-2007-999409","article-title":"Anaerobic coverage for intra-amniotic infection: maternal and perinatal impact","volume":"8","author":"Maberry","year":"1991","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib43","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000151106.87930.1a","article-title":"High compared with standard gentamicin dosing for chorioamnionitis: a comparison of maternal and fetal serum drug levels","volume":"105","author":"Locksmith","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.clinthera.2016.08.005_bib44","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3109\/14767058.2015.1058773","article-title":"Risk factors for post-operative wound infection in the setting of chorioamnionitis and cesarean delivery","volume":"29","author":"Dotters-Katz","year":"2016","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clinthera.2016.08.005_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3109\/14767058.2011.594117","article-title":"Ertapenem compared to combination drug therapy for the treatment of postpartum endometritis after cesarean delivery","volume":"25","author":"Brown","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.clinthera.2016.08.005_bib46","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1053\/j.semperi.2014.08.017","article-title":"Is personalized medicine achievable in obstetrics?","volume":"38","author":"Quinney","year":"2014","journal-title":"Semin Perinatol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181630652X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929181630652X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:37:21Z","timestamp":1568367441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929181630652X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S014929181630652X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.08.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principles of Anti-infective Dosing in Pregnancy","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}